NO20052628D0 - New pyrimidine-4,6-dicarboxamides for selective inhibition of collagenases - Google Patents
New pyrimidine-4,6-dicarboxamides for selective inhibition of collagenasesInfo
- Publication number
- NO20052628D0 NO20052628D0 NO20052628A NO20052628A NO20052628D0 NO 20052628 D0 NO20052628 D0 NO 20052628D0 NO 20052628 A NO20052628 A NO 20052628A NO 20052628 A NO20052628 A NO 20052628A NO 20052628 D0 NO20052628 D0 NO 20052628D0
- Authority
- NO
- Norway
- Prior art keywords
- dicarboxamides
- collagenases
- selective inhibition
- new pyrimidine
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10251019A DE10251019A1 (en) | 2002-11-02 | 2002-11-02 | New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| DE10254092A DE10254092A1 (en) | 2002-11-20 | 2002-11-20 | New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| PCT/EP2003/011515 WO2004041788A1 (en) | 2002-11-02 | 2003-10-18 | Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20052628D0 true NO20052628D0 (en) | 2005-05-31 |
| NO20052628L NO20052628L (en) | 2005-07-08 |
| NO330345B1 NO330345B1 (en) | 2011-03-28 |
Family
ID=32313538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052628A NO330345B1 (en) | 2002-11-02 | 2005-05-31 | Pyrimidine-4,6-dicarboxylic acid diamides, process for their preparation and composition containing at least one such compound |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1560815B1 (en) |
| JP (1) | JP4564359B2 (en) |
| KR (1) | KR101050680B1 (en) |
| AR (1) | AR043058A1 (en) |
| AT (1) | ATE388941T1 (en) |
| AU (1) | AU2003301847A1 (en) |
| BR (1) | BR0315055A (en) |
| CA (1) | CA2504153C (en) |
| CO (1) | CO5700759A2 (en) |
| DE (1) | DE50309381D1 (en) |
| DK (1) | DK1560815T3 (en) |
| ES (1) | ES2298621T3 (en) |
| HK (1) | HK1083503A1 (en) |
| HR (1) | HRP20050382B1 (en) |
| MA (1) | MA27412A1 (en) |
| MX (1) | MXPA05004365A (en) |
| MY (1) | MY135375A (en) |
| NO (1) | NO330345B1 (en) |
| PE (1) | PE20040605A1 (en) |
| PL (1) | PL375044A1 (en) |
| PT (1) | PT1560815E (en) |
| RS (1) | RS20050294A (en) |
| RU (1) | RU2344129C2 (en) |
| TW (1) | TWI316512B (en) |
| WO (1) | WO2004041788A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060173183A1 (en) * | 2004-12-31 | 2006-08-03 | Alantos Pharmaceuticals, Inc., | Multicyclic bis-amide MMP inhibitors |
| BRPI0609802A2 (en) * | 2005-05-20 | 2017-05-02 | Alantos Pharmaceuticals Holding Inc | compound, pharmaceutical composition and use of a compound |
| US20070155738A1 (en) | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| WO2008002671A2 (en) * | 2006-06-29 | 2008-01-03 | Alantos Pharmaceuticals Holding, Inc. | Metalloprotease inhibitors |
| US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
| CL2008001933A1 (en) | 2007-06-29 | 2009-09-25 | Millennium Pharm Inc | Pyrimidine derived compounds, raph kinase inhibitors; intermediate compounds; preparation procedure; pharmaceutical composition; and its use to treat proliferative, cardiac, neurodegenerative, inflammatory, bone, immunological, viral disease, among others. |
| AR068509A1 (en) * | 2007-09-19 | 2009-11-18 | Jerini Ag | BRADIQUININE B1 RECEIVER ANTAGOSNIST |
| US8912184B1 (en) | 2010-03-01 | 2014-12-16 | Alzheimer's Institute Of America, Inc. | Therapeutic and diagnostic methods |
| US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| US9035072B2 (en) | 2010-04-22 | 2015-05-19 | Vertex Pharmaceuticals Incorporated | Process of producing cycloalkylcarboxamido-indole compounds |
| AR086113A1 (en) | 2011-04-30 | 2013-11-20 | Abbott Lab | ISOXAZOLINS AS THERAPEUTIC AGENTS |
| PL3424534T3 (en) | 2014-04-15 | 2021-11-22 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931432A1 (en) * | 1989-09-21 | 1991-04-04 | Hoechst Ag | PYRIMIDIN-4,6-DICARBONSAEUREDIAMIDE, METHOD FOR THE PRODUCTION AND USE THEREOF AND MEDICINAL PRODUCTS BASED ON THESE COMPOUNDS |
| WO2002064571A1 (en) | 2001-02-14 | 2002-08-22 | Warner-Lambert Company Llc | Pyrimidine matrix metalloproteinase inhibitors |
| DOP2002000332A (en) * | 2001-02-14 | 2002-08-30 | Warner Lambert Co | MATRIX METALOPROTEINAS PYRIDINE INHIBITORS |
| DE10160357A1 (en) * | 2001-12-08 | 2003-06-18 | Aventis Pharma Gmbh | Use of pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides for the selective inhibition of collagenases |
-
2003
- 2003-10-18 DE DE50309381T patent/DE50309381D1/en not_active Expired - Lifetime
- 2003-10-18 EP EP03810401A patent/EP1560815B1/en not_active Expired - Lifetime
- 2003-10-18 CA CA2504153A patent/CA2504153C/en not_active Expired - Fee Related
- 2003-10-18 AU AU2003301847A patent/AU2003301847A1/en not_active Abandoned
- 2003-10-18 WO PCT/EP2003/011515 patent/WO2004041788A1/en active IP Right Grant
- 2003-10-18 PT PT03810401T patent/PT1560815E/en unknown
- 2003-10-18 ES ES03810401T patent/ES2298621T3/en not_active Expired - Lifetime
- 2003-10-18 RS YUP-2005/0294A patent/RS20050294A/en unknown
- 2003-10-18 MX MXPA05004365A patent/MXPA05004365A/en active IP Right Grant
- 2003-10-18 PL PL03375044A patent/PL375044A1/en unknown
- 2003-10-18 JP JP2004548752A patent/JP4564359B2/en not_active Expired - Fee Related
- 2003-10-18 BR BR0315055-0A patent/BR0315055A/en not_active Application Discontinuation
- 2003-10-18 KR KR1020057007598A patent/KR101050680B1/en not_active IP Right Cessation
- 2003-10-18 RU RU2005116847/04A patent/RU2344129C2/en not_active IP Right Cessation
- 2003-10-18 AT AT03810401T patent/ATE388941T1/en active
- 2003-10-18 DK DK03810401T patent/DK1560815T3/en active
- 2003-10-27 PE PE2003001085A patent/PE20040605A1/en not_active Application Discontinuation
- 2003-10-29 TW TW092129976A patent/TWI316512B/en not_active IP Right Cessation
- 2003-10-30 AR ARP030103974A patent/AR043058A1/en not_active Application Discontinuation
- 2003-10-30 MY MYPI20034144A patent/MY135375A/en unknown
-
2005
- 2005-04-29 MA MA28244A patent/MA27412A1/en unknown
- 2005-04-29 CO CO05041024A patent/CO5700759A2/en not_active Application Discontinuation
- 2005-04-29 HR HRP20050382AA patent/HRP20050382B1/en not_active IP Right Cessation
- 2005-05-31 NO NO20052628A patent/NO330345B1/en not_active IP Right Cessation
-
2006
- 2006-03-20 HK HK06103488A patent/HK1083503A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0315055A (en) | 2005-08-16 |
| AR043058A1 (en) | 2005-07-13 |
| KR20050067212A (en) | 2005-06-30 |
| JP4564359B2 (en) | 2010-10-20 |
| CA2504153C (en) | 2012-07-03 |
| DE50309381D1 (en) | 2008-04-24 |
| WO2004041788A1 (en) | 2004-05-21 |
| CA2504153A1 (en) | 2004-05-21 |
| AU2003301847A1 (en) | 2004-06-07 |
| MA27412A1 (en) | 2005-06-01 |
| RS20050294A (en) | 2007-11-15 |
| MXPA05004365A (en) | 2005-07-05 |
| NO20052628L (en) | 2005-07-08 |
| ATE388941T1 (en) | 2008-03-15 |
| CO5700759A2 (en) | 2006-11-30 |
| EP1560815B1 (en) | 2008-03-12 |
| TWI316512B (en) | 2009-11-01 |
| HRP20050382B1 (en) | 2013-09-30 |
| JP2006513158A (en) | 2006-04-20 |
| PL375044A1 (en) | 2005-11-14 |
| NO330345B1 (en) | 2011-03-28 |
| PT1560815E (en) | 2008-04-07 |
| TW200418808A (en) | 2004-10-01 |
| KR101050680B1 (en) | 2011-07-21 |
| ES2298621T3 (en) | 2008-05-16 |
| DK1560815T3 (en) | 2008-06-16 |
| RU2005116847A (en) | 2006-01-20 |
| RU2344129C2 (en) | 2009-01-20 |
| MY135375A (en) | 2008-04-30 |
| EP1560815A1 (en) | 2005-08-10 |
| HRP20050382A2 (en) | 2006-12-31 |
| PE20040605A1 (en) | 2004-10-15 |
| HK1083503A1 (en) | 2006-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052628D0 (en) | New pyrimidine-4,6-dicarboxamides for selective inhibition of collagenases | |
| ATE368651T1 (en) | PYRIDAZINONE DERIVATIVES AS GSK-3BETA INHIBITORS | |
| DE60313872D1 (en) | PYRAZOLOE1,5-ATPYRIMIDINES AS INHIBITORS CYCLINE-DEPENDENT KINASES | |
| NO20033635L (en) | Pyrimidine derivatives for cell proliferation inhibition | |
| DK1534290T3 (en) | New kinase inhibitors | |
| ATE452891T1 (en) | PYRIMIDOPYRIMIDONES AS KINASE INHIBITORS | |
| IS8006A (en) | Substituted pyrimidinone | |
| DK1633726T3 (en) | Pyrimidine derivatives suitable for the treatment of CRTH2-mediated diseases | |
| IS7717A (en) | Pyridazinone derivatives as PDF4 inhibitors | |
| DE602004012154D1 (en) | PYRIDOÄ2,3-DÜPYRIMIDIN-2,4-DIAMINE AS PDE-2 INHIBITORS | |
| NO20053775D0 (en) | Diazepinoindole derivatives as kinase inhibitors. | |
| NO20053340D0 (en) | Substituted dihydropyranoindole-3,4-dione derivatives as inhibitors of plasmogenogen activator-1 (CPAI-1). | |
| NO20034308L (en) | New tyrokinase inhibitors | |
| NO20052497D0 (en) | Methods for selective inhibition of Janus tyrosine kinase 3 (JAK3). | |
| ATE346070T1 (en) | PURINE DERIVATIVES AS KINASE INHIBITORS | |
| EP1675552A4 (en) | Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors | |
| NO20033679D0 (en) | New pyrimidine compounds | |
| DE60322544D1 (en) | GLYCINAMIDE DERIVATIVES AS RAF KINASE INHIBITORS | |
| DE60328978D1 (en) | ISOCHINOLINE DERIVATIVES AS MAO-B INHIBITORS | |
| DE60317684D1 (en) | SUBSTITUTED 2,4-DIHYDROPYRROLOc3,4BUCHINOLINE-9-ON DERIVATIVES SUITABLE AS PHOSPHODIESTERASE INHIBITORS | |
| ES1053304Y (en) | IMPROVED PROVISION FOR THE SETTING OF SINKS. | |
| NO20054141D0 (en) | Substituted 2- (diaza-bicycloalkyl) pyrimidone derivatives | |
| NO20035206D0 (en) | Pyrimidine derivatives useful as selective COX-2 inhibitors | |
| NO20031320D0 (en) | System for classification of seabed unevenness | |
| NO20053911D0 (en) | Diazepine derivatives useful as LFA inhibitors. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |